Early-life factors contributing to type 1 diabetes
Craig ME, Kim KW, Isaacs SR, et al.
Diabetologia. 2019, 62:1823-34
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Husain M, Birkenfeld AL, Donsmark M, et al.
N Engl J Med. 2019;381(9):841-51
Leggi
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions with Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry)
Pepe M, Sardella G, Stefanini GG, et al.
American Journal of Cardiology. Pub online 23 August 2019
Leggi
Ticagrelor In Patients with Diabetes and Stable Coronary Artery Disease with A History of Previous Percutaneous Coronary Intervention (THEMIS-PCI): A Phase 3, Placebo-Controlled, Randomised Trial
Bhatt DL, Steg PG, Mehta SR, et al.
Lancet Diabetes Endocrinol. Pub online 1 September 2019
Leggi
Risk of Diabetes-Associated Diseases in Subgroups of Patients with Recent-Onset Diabetes: A 5-Year Follow-Up Study
Zaharia OP, Strassburger K, Strom A, et al.
Lancet Diabetes 2019;7(9):684-94
Leggi
Type 1 Diabetes Advances Could Pave Way for Prevention
Abbasi J
JAMA. Pub online 21 August 2019
Leggi
Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes
Chamberlain JJ, Doyle-Delgado K, Peterson L, Skolnik N
Annals of Internal Medicine. Pub online13 August 2019
Leggi
Fifteen Years Trends of Cardiogenic Shock and Mortality in Patients with Diabetes and Acute Coronary Syndromes
Dauriz M, Moric N, Gonzini L, et al.
Am J Med. Pub online 22 Aug 2019
Leggi
Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week
Wang A, Green JB, Halperin JL, Piccini JP Sr
J Am Coll Cardiol. 2019;74(8):1107-15
Leggi
Novel Metabolic Indices and Incident Type 2 Diabetes Among Women and Men: The Rotterdam Study
Brahimaj A, Rivadeneira F, Muka T, et al.
Diabetologia. 2019;62:1581-90
Leggi